Issue 18, 2020

Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain

Abstract

Interleukin-13 (IL-13) drives cells of myeloid origin towards a more anti-inflammatory phenotype, but delivery to the brain remains problematic. Herein, we show that heparin-based cryogel microcarriers load high amounts of IL-13, releasing it slowly. Intra-striatal injection of loaded microcarriers caused local up-regulation of ARG1 in myeloid cells for pro-regenerative immunomodulation in the brain.

Graphical abstract: Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain

Supplementary files

Article information

Article type
Communication
Submitted
28 Jul 2020
Accepted
01 Sep 2020
First published
01 Sep 2020
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2020,8, 4997-5004

Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain

L. Schirmer, C. Hoornaert, D. Le Blon, D. Eigel, C. Neto, M. Gumbleton, P. B. Welzel, A. E. Rosser, C. Werner, P. Ponsaerts and B. Newland, Biomater. Sci., 2020, 8, 4997 DOI: 10.1039/D0BM01249A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements